Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q4 FY23 results · Jan–Mar 2023

Advanced Enzyme Technologies reported revenue from operations of ₹138.71 crore (up 5.3% from Q4 FY22) and net profit of ₹32.12 crore (up 27.2% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations138.71131.73+5.3%142.11−2.4%
Other income11.083.38+227.6%8.52+30.1%
Total income149.79135.12+10.9%150.63−0.6%
Profit before tax42.1033.95+24.0%40.45+4.1%
Net profit for the period32.1225.25+27.2%27.91+15.1%
Attributable to shareholders of the company32.1224.43+31.5%29.44+9.1%
EPS, basic (₹)2.872.19+31.1%2.63+9.1%
Net margin (%)23.219.219.6
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations82.5670.75+16.7%79.68+3.6%
Other income2.815.17−45.6%3.75−25.1%
Total income85.3775.92+12.5%83.44+2.3%
Profit before tax23.2817.97+29.6%22.31+4.3%
Net profit for the period17.5014.35+21.9%16.64+5.2%
EPS, basic (₹)1.561.28+21.9%1.49+4.7%
Net margin (%)21.220.320.9
Consolidated
Filed with BSE
15 May 2023, 12:42 IST
Board meeting
13 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
15 May 2023, 12:42 IST
Board meeting
13 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE